Anticipating and Responding to Knowledge Translation Needs During a Pandemic
Join us on Tuesday, December 7th, as we hear from Pablo Navarro, MSc, BSc.
Find a Resource
We encourage you to use our list of trusted resources, digital library, and misinformation tools.
Subscribe to Our Weekly Newsletter
We send out weekly updates to our members via email.
CanCOVID membership is free. Participate in our real-time collaboration and knowledge exchange.
Our purpose is to support the scientific effort and community in their work through encouraging multidisciplinary collaborations and helping to connect people and resources to enable rapid knowledge mobilization and science-to-policy action. We are also committed to helping to provide our government partners with a better line of sight to existing and emerging COVID‑19 science and research.
Our partners and collaborators consist of academic, science-related and government institutions. We cross promote and share resources to connect our members to COVID‑19 information, and to facilitate our members’ contribution to decision-making.
Our members engage and collaborate with an interdisciplinary network through a Slack platform, including Canada’s leading scientists, researchers, and academics. They receive the latest insights, can share their work through Slack or through our Speakers Series and Workshops, and can find potential collaborators to work with on COVID‑19 initiatives.
On this page, you will find a glimpse of our latest knowledge products, a reference list of Canada’s response to COVID-19, and hear from some of the voices in our community.
Interactive COVID‑19 Trackers
Explore our new C-19 Trackers pages, featuring interactive dashboards on trending COVID‑19 data. Updated daily, these provincial, national, and international tools can be used to find specific data sets.
Our Knowledge Products
The following collection of resources relating to COVID‑19 research was developed by members of the CanCOVID Community. They include rapid reviews and issue notes, among other types of products.
Impact of Restrictive Public Health Measures on Long-Term Care Residents, Family, and Staff
COVID‑19 Infection Prevention and Control (IPAC) in Long-Term Care Facilities in two OECD countries, the Netherlands and Denmark: Best Practices, Implementation, Compliance
Key considerations for introducing and lifting public health measures in kindergarten, elementary, secondary, and post-secondary schools
Interventions to improve infection prevention and control for COVID‑19 in long-term care homes
Key considerations and emerging evidence of experience across jurisdictions implementing documentation of vaccination
Experience and evidence with COVID‑19 transmission and spread across jurisdictions related to changes in border controls
Misinformation and disinformation in relation to COVID‑19
Determinants of COVID‑19 vaccination hesitancy and ways to improve vaccine acceptance and confidence
Canada’s Response to COVID‑19
This list presents national advisory committees, task forces, and research networks supporting an evidence-based response to COVID‑19 for Canada, providing information to inform policy and practice at the national level. Please let us know about other key advisory bodies we may have missed by contacting us at firstname.lastname@example.org.
National Advisory Committees and Task Forces
- Appointed to provide scientific advice to the government of Canada.
- The CSA has established several advisory groups on COVID-19.
A federal-provincial-territorial expert group, co-chaired by Canada’s Chief Public Health Officer, Dr. Theresa Tam, and a rotating provincial Chief Public Health Officer (CPHO), which brings together Canada’s chief public health officers to address COVID-19, including the development of public health guidance.
Provides advice to PHAC and Canadians on immunization programs, appropriate vaccines, and appropriate target populations.
A team of experts and industry leaders providing information about safety, development, and delivery of vaccines for Canada.
A team of industry leaders and scientific advisors who assess and prioritize COVID‑19 therapeutics for Canada.
A team of experts working with the public health agency, focusing on tracking, research, testing, and estimates of immunity.
Provides evidence-informed advice to the federal government on science and policy related to innovative approaches to testing.
Currently has a wide-ranging series of policy briefings, media reports, and work plans on many aspects of COVID-19, synthesizing available information and advice from leading Canadian experts for decision makers.
Provides guidance on ethical issues and questions related to agency programs and services.
A CIHR-funded national network of key vaccine researchers who develop and test methods for evaluating vaccines regarding safety, immunogenicity and effectiveness, as well as program implementation and evaluation.
British Columbia Centre for Disease Control, Vancouver, British Columbia
St. Francis Xavier University, Antigonish, Nova Scotia
Institut national de la santé publique du Québec, Montréal, Québec
University of Northern British Columbia, Prince George, British Columbia
University of Manitoba, Winnipeg, Manitoba
McMaster University, Hamilton, Ontario
National Research Networks
A CIHR-funded international network that is working to provide the best available evidence to support decision-making and researchers involved in the pandemic response.
A CIHR-funded national network that will enable the rapid assessment of both the immune response to the virus variants and any resistance to existing vaccines. To provide decision makers with guidance regarding drug therapy, vaccine effectiveness, and other public health strategies.
COVID-END is a CIHR-funded network with 50 world leaders in producing syntheses, technology assessments and guidelines. Find access to best available evidence on a full range of COVID‑19 topics.